Quality standard

Quality statements

Quality statements

Statement 1 Adults who are having transurethral resection of bladder tumour (TURBT) have detrusor muscle obtained during the procedure.

Statement 2 Adults with suspected bladder cancer are offered a single dose of intravesical mitomycin C, given at the same time as the first TURBT.

Statement 3 Adults with bladder cancer have access to a designated clinical nurse specialist.

Statement 4 Adults with newly diagnosed non‑muscle‑invasive bladder cancer have a risk classification of their cancer completed.

Statement 5 Adults with high‑risk non‑muscle‑invasive bladder cancer discuss intravesical Bacille Calmette‑Guérin (BCG) and radical cystectomy with a urologist who performs both treatments and a clinical nurse specialist.

Statement 6 Adults with muscle‑invasive urothelial bladder cancer discuss neoadjuvant chemotherapy, radical cystectomy and radiotherapy using a radiosensitiser with a urologist who performs radical cystectomy, a clinical oncologist and a clinical nurse specialist.

Statement 7 Adults who have had low‑risk non‑muscle‑invasive bladder cancer and who have no recurrence of the bladder cancer within 12 months of their initial TURBT are discharged to primary care.